Miguel Abboud to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Miguel Abboud has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.980
-
Implementation of an intensive risk-stratified treatment protocol for children and adolescents with acute lymphoblastic leukemia in Lebanon. Am J Hematol. 2012 Jul; 87(7):678-83.
Score: 0.310
-
Clinical presentation and treatment outcome of children with Burkitt lymphoma in Lebanon: a single institution's experience. J Pediatr Hematol Oncol. 2004 Nov; 26(11):749-53.
Score: 0.184
-
Isolated Central Nervous System Relapse Following Treatment Reduction in Low-risk Acute Lymphoblastic Leukemia at the Children's Cancer Center of Lebanon. J Pediatr Hematol Oncol. 2020 08; 42(6):e428-e433.
Score: 0.137
-
Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon. J Glob Oncol. 2019 04; 5:1-8.
Score: 0.125
-
Cyclophosphamide and topotecan as first-line salvage therapy in patients with relapsed ewing sarcoma at a single institution. J Pediatr Hematol Oncol. 2013 Jul; 35(5):356-60.
Score: 0.084
-
Thrombosis in children with acute lymphoblastic leukemia treated at a tertiary care center in Lebanon: revisiting the role of predictive models. Pediatr Hematol Oncol. 2011 Nov; 28(8):676-81.
Score: 0.073
-
Vincristine-induced neurotoxicity in pediatric patients with rhabdomyosarcoma: A retrospective analysis of clinical features and outcome. Pediatr Hematol Oncol. 2022 Oct; 39(7):644-649.
Score: 0.038
-
Successful treatment of relapsed infant acute lymphoblastic leukemia with intensive antimetabolite-based chemotherapy. Med Pediatr Oncol. 1997 Oct; 29(4):256-9.
Score: 0.028